Nadrich & Cohen Accident Injury Lawyers is currently investigating Inferior Vena Cava Filter (IVC Filter) on behalf of patients who were injured due to one of the following defective devices:
- C.R. Bard
- Bard G2
- Bard G2 Express
- Bard Recovery
- Bard Eclipse
- Bard Recovery
- Cook Medical
- Cook Celect
- Cook Günther Tulipe
Our experienced legal team has taken on some of the world’s largest corporations. We have represented thousands of patients injured due to defective medical devices. We have the resources and knowledge required to successfully resolve IVC Filter defect claims.
If you or a loved one has been injured or died due to a defective IVC Filter device, immediately contact our office to speak with one of our IVC Filter Lawsuit attorneys. We offer a free, confidential case evaluation. Call us now at 1-800-718-4658. We are a California law firm handling IVC Filter claims, but represent clients throughout the country.
Reported IVC Filter Complications
- Device Fracture, Tilting, Migration
- Filter Perforation, Puncture or Damage
- Cardiac and Pericardial tamponade
- Cardiac arrhythmia
- Ventricle Tachycardia
- Caudal and Cephalad Migration
- Internal Bleeding
IVC Filter Defects
Vena cava filters have been used by the medical community in the United States since the 1960s. C. R. Bard first obtained FDA clearance to market these devices more than a decade ago. IVC Filters are implanted in a major blood vessel called the inferior vena cava, and they are supposed to reduce a patient’s risk of death by preventing pulmonary embolisms (blood clot in the lungs). Unfortunately, they have been linked to many life-threatening complications.
The Bard retrievable IVC filter has been shown to have an accelerated failure risk and serious side effects. Studies have shown that the filter fractures and migrates in up to between 20 to 30% of patients use. A study found that the Cook Celect IVC Filter had a 43% perforation risk after implantation. Other IVC devices have a much lower failure and perforation rate.
A federal jury in Portland, Oregon recently awarded almost $1 million to a man who alleged a Bard Eclipse IVC filter perforated his vena cava. The jury found the device’s design to be negligent, and that the device’s manufacturer should have, but failed to, warn about the risks of the device.
Adverse Reports and FDA Warnings For IVC Devices
Surgeons implant retrievable Inferior Vena Cava filters (IVCs) in the veins of patients who are unable to take anticoagulants (blood thinners) in order to prevent blood clots from moving to the lungs. IVCs catch the clots in the blood stream and, over time, the clots dissipate. But the U.S. Food & Drug Administration (FDA) received hundreds of adverse reports about the retrievable filters. Reported complications included punctured organs, blood vessels and filter migration to different parts of the body.
In 2010, the FDA warned the retrievable filters posed risks of filter fracture, device migration, and organ perforation and should be removed as soon as the patient’s risk for blood clots subsided. The FDA updated safety communication in 2014, stating most devices should be removed between the 29th and 54th day after implantation. But the warning signs came too late for some. Plaintiffs began filing lawsuits across the country claiming the filters caused harm and death.
How To Join The IVC Filter Lawsuit
Nadrich & Cohen Accident Injury Lawyers and its legal team are actively pursuing IVC lawsuits. Our Defective Medical Device Team is actively investigating IVC claims against Bard, Cook Medical and Cordis. Our team of lawyers has extensive experience pursuing defective medical device lawsuit claims and has recovered over $350,000,000 on behalf of injury victims and their families.
If you or your loved one has suffered the side effect stated above because of the Bard, Cook Medical or Cordis IVC filter you may be entitled to financial recovery. Call us now for a free case evaluation. The call is 100% confidential and free of charge. Don’t delay call 1-800-718-4658 now, use the live chat or complete the contact form on this page.